Siddharth Mittal, Ceo & Md, Biocon With Kumaar Bagrodia, Founder, Neuroleap

Big Pharma Firm Biocon's MD & CEO Siddharth Mittal On The Booming Obesity And Diabetes Drug Market

Biocon @45: Together We Thrive | Siddharth Mittal Speech at Biocon Campus

Biocon Biologics

Siddharth Mittal, CEO & MD, Biocon with Kumaar Bagrodia, Founder, NeuroLeap

CLO Chief Learning Officers Summit India

Biocon To Invest $500 Mn For Capacities In Generics Biz In 5 Years Says MD & CEO, Siddharth Mittal

Biocon' Siddharth Mittal On Pipeline Of Biosimilar & Generic Drugs | BQ Prime

Biocon's Siddharth Mittal Speaks On Selling Stake In Syngene & Viatris Biologics Biz Acquisition

The Vision Board Interview With Mr. Siddharth Mittal | Marketing Director | Auto International

Siddharth Mittal

Siddharth Mittal, CEO & MD, Biocon, On Q4 Earnings, Pharma Market & Plans For Overseas Markets

Biocon Sells Another 10% Stake In Syngene: Siddharth Mittal Speaks On The Firm's Fund Raise Pipeline

Siddharth Mittal in conversation with Alok Sinha & Sangram Surve

Guts, Glory & Story

Growth of Company or Individual by Siddharth Mittal In #MirketaRadiance

Mirketa Radiance

Pharma firm Biocon elevates CFO Siddharth Mittal to CEO, joint MD

Biocon's Q2 Results Decoded. Exclusive Interview With Biocon's Management On Earnings & Plans Ahead

“Big market opportunity...” India's pharma giant eyes Chinese market

Biocon Ltd ADR BCNQY CEO Siddharth Mittal on Q3 2020 Results

Daily Earnings Calls

Biocon Ltd BCNQY CEO Siddharth Mittal on Q1 2021 Results

Daily Earnings Calls

Panel Session : New models of Partnership At THE ECONOMIC TIMES CFO SUMMIT 2015

Q1 Review: Biocon's Profit, Margins Fall, Misses Estimates | BQ Prime

Biocon Q1 Earnings: PAT Soars 6X! Margin Miss, Growth Recovery Guidance & More | Siddharth Mittal

Biocon Q1 Results: Profit Drops 30% YoY To Rs 101 Cr | Siddharth Mittal | ET Now